This presentation introduces the work of MMV and then describes the problem of access to effective antimalarials such as artemisinin combination therapy, the need to involve both the public and private sectors to solve this problem, and MMV's work in partnership with other organizations to do this and so improve availability, affordability, acceptabilty, quality and delivery